Are oxidative stress - Activated signaling pathways mediators of insulin resistance and β-cell dysfunction?

Diabetes

Volumn 52, Issue 1, 2003, Pages 1-8

  Evans, Joseph L ^a   Goldfine, Ira D ^b   Maddux, Betty A ^b   Grodsky, Gerold M ^b  

^a Medical Research Institute   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; ACETYLSALICYLIC ACID; ALPHA TOCOPHEROL; AMINOGUANIDINE; ASCORBIC ACID; FATTY ACID; GLUCOSE TRANSPORTER 4; GLUTATHIONE; HEXOSAMINE; HYDROXYL RADICAL; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LEPTIN; LIPID; M PROTEIN; MALONALDEHYDE; MITOGEN ACTIVATED PROTEIN KINASE; N TERT BUTYL ALPHA PHENYLNITRONE; PROTEIN SERINE KINASE; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; RUBOXISTAURIN; STRESS ACTIVATED PROTEIN KINASE; SUPEROXIDE; SYNAPTOPHYSIN; THIOCTIC ACID; ZINC OXIDE;

CALORIC INTAKE; CELL CULTURE; CHO CELL; CLINICAL RESEARCH; CLINICAL TRIAL; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; DIABETIC OBESITY; DIABETIC RETINOPATHY; DNA STRAND BREAKAGE; ENVIRONMENTAL FACTOR; GENE ACTIVATION; GENETIC PREDISPOSITION; GLUCOSE BLOOD LEVEL; GLUCOSE CLAMP TECHNIQUE; GLUCOSE TRANSPORT; HORMONAL REGULATION; HUMAN; HYPERGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RELEASE; INSULIN RESISTANCE; KNOCKOUT MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PANCREAS ISLET BETA CELL; PANCREAS ISLET DISEASE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REVIEW; TISSUE INJURY;

ANIMALS; DIABETES MELLITUS, TYPE 2; HUMANS; HYPERGLYCEMIA; INSULIN RESISTANCE; ISLETS OF LANGERHANS; OXIDATIVE STRESS; SIGNAL TRANSDUCTION;

EID: 0037219409     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.52.1.1     Document Type: Review

References (108)

1. DeFronzo RA: Pathogenesis of type 2 diabetes: Metabolic and molecular implications for identifying diabetes genes. Diabetes Review 5:177-269, 1997
2. Kahn CR, Vicent D, Doria A: Genetics of non-insulin-dependent (type-II) diabetes mellitus. Annu Rev Med 47:509-531, 1996
3. Unger RH, Foster DW: Diabetes mellitus. In Williams Textbook of Endocrinology. Wilson JD, Foster DW, Kronenberg HM, Larsen PR, Eds. Philadelphia, Saunders, 1998, p. 973-1059
4. The Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977-986, 1993
5. McGarry JD: Banting Lecture 2001: Dysregulation of fatty acid metabolism in the etiology of type 2 diabetes. Diabetes 51:7-18, 2002
6. Boden G: Role of fatty acids in the pathogenesis of insulin resistance and NIDDM. Diabetes 46:3-10, 1997
7. Poitout V, Robertson RP: Minireview: Secondary beta-cell failure in type 2 diabetes - A convergence of glucotoxicity and lipotoxicity. Endocrinology 143:339-342, 2002
8. Harmon JS, Gleason CE, Tanaka Y, Poitout V, Robertson RP: Antecedent hyperglycemia, not hyperlipidemia, is associated with increased islet triacylglycerol content and decreased insulin gene mRNA level in Zucker diabetic fatty rats. Diabetes 50:2481-2486, 2001
9. Rosen P, Nawroth PP, King G, Moller W, Tritschler HJ, Packer L: The role of oxidative stress in the onset and progression of diabetes and its complications: A summary of a Congress Series sponsored by UNESCO-MCBN, the American Diabetes Association, and the German Diabetes Society. Diabetes Metab Res Rev 17:189-212, 2001
10. Brownlee M: Biochemistry and molecular cell biology of diabetic complications. Nature 414:813-820, 2001
11. Nishikawa T, Edelstein D, Brownlee M: The missing link: A single unifying mechanism for diabetic complications. Kidney Int 58:26-30, 2000
12. Brownlee M: Advanced protein glycosylation in diabetes and aging. Annu Rev Med 46:223-234, 1995
13. Koya D, King GL: Protein kinase C activation and the development of diabetic complications. Diabetes 47:859-866, 1998
14. Brownlee M, Cerami A: The biochemistry of the complications of diabetes mellitus. Annu Rev Biochem 50:385-432, 1981
15. Wolff SP, Dean RT: Glucose autoxidation and protein modification: The potential role of 'autoxidative glycosylation' in diabetes. Biochem J 245:243-250, 1987
16. Stevens MJ, Obrosova I, Feldman EL, Greene DA: The sorbitol-osmotic and sorbitol-redox hypothesis. In Diabetes Mellitus: A Fundamental and Clinical Text. LeRoith D, Taylor SI, Olefsky JM, Eds. Philadelphia, Lippincott Williams & Wilkins, 2000, p. 972-983
17. Barnes PJ, Karin M: Nuclear factor-kappaB: A pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 336:1066-1071, 1997
18. Kyriakis JM, Avruch J: Sounding the alarm: Protein kinase cascades activated by stress and inflammation. J Biol Chem 271:24313-24316, 1996
19. Marshall S, Garvey WT, Traxinger RR: New insights into the metabolic regulation of insulin action and insulin resistance: Role of glucose and amino acids. FASEB J 5:3031-3036, 1991
20. Mohamed AK, Bierhaus A, Schiekofer S, Tritschler H, Ziegler R, Nawroth PP: The role of oxidative stress and NF-κB activation in late diabetic complications. Biofactors 10:157-167, 1999
21. Bierhaus A, Schiekofer S, Schwaninger M, Andrassy M, Humpert PM, Chen J, Hong M, Luther T, Henle T, Kloting I, Morcos M, Hofmann M, Tritschler H, Weigle B, Kasper M, Smith M, Perry G, Schmidt AM, Stern DM, Haring HU, Schleicher E, Nawroth PP: Diabetes-associated sustained activation of the transcription factor nuclear factor-κB. Diabetes 50:2792-2808, 2001
22. Nishikawa T, Edelstein D, Du XL, Yamagishi S, Matsumura T, Kaneda Y, Yorek MA, Beebe D, Oates PJ, Harames HP, Giardino I, Brownlee M: Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 404:787-790, 2000
23. Ho FM, Liu SH, Liau CS, Huang PJ, Lin-Shiau SY: High glucose-induced apoptosis in human endothelial cells is mediated by sequential activations of c-Jun NH(2)-terminal kinase and caspase-3. Circulation 101:2618-2624, 2000
24. Natarajan R, Scott S, Bai W, Yerneni KKV, Nadler J: Angiotensin II signaling in vascular smooth muscle cells under high glucose conditions. Hypetension 33:378-384, 1999
25. Begum N, Ragolia L: High glucose and insulin inhibit VSMC MKP-1 expression by blocking iNOS via p38 MAPK activation. Am J Physiol 278:C81-C91, 2000
26. Igarashi M, Wakasaki H, Takahara N, Ishii H, Jiang ZY, Yamauchi T, Kuboki K, Meier M, Rhodes CJ, King GL: Glucose or diabetes activates p38 mitogen-activated protein kinase via different pathways. J Clin Invest 103:185-195, 1999
27. Dunlop ME, Muggli EE: Small heat shock protein alteration provides a mechanism to reduce mesangial cell contractility in diabetes and oxidative stress. Kidney Int 57:464-475, 2000
28. Purves T, Middlemas A, Agthong S, Jude EB, Boulton AJ, Femyhough P, Tomlinson DR: A role for mitogen-activated protein kinases in the etiology of diabetic neuropathy. FASEB J 15:2508-2514, 2001
29. Boden G, Chen X, Ruiz J, White JV, Rossetti L: Mechanisms of fatty acid-induced inhibition of glucose uptake. J Clin Invest 93:2438-2446, 1994
30. Schleicher ED, Weigert C: Role of the hexosamine biosynthetic pathway in diabetic nephropathy. Kidney Int 58 (Suppl. 77):S13-S18, 2000
31. Du XL, Edelstein D, Rossetti L, Fantus IG, Goldberg H, Ziyadeh F, Wu J, Brownlee M: Hyperglycemia-induced mitochondrial superoxide overproduction activates the hexosamine pathway and induces plasminogen activator inhibitor-1 expression by increasing Sp1 glycosylation. Proc Natl Acad Sci U S A 97:12222-12226, 2000
32. Reaven GM: Insulin resistance and its consequences: type 2 diabetes mellitus and coronary heart disease. In Diabetes Mellitus: A Fundamental and Clinical Text. LeRoith D, Taylor SI, Olefsky JM, Eds. Philadelphia, Lippincott Williams & Wilkins, 2000, p. 604-615
33. Kahn CR: Insulin action, diabetogenes, and the cause of type 2 diabetes. Diabetes 43:1066-1084, 1994
34. Grodsky GM: Kinetics of insulin secretion: Underlying metabolic events in diabetes mellitus. In Diabetes Mellitus: A Fundamental and Clinical Text. Le Roith D, Taylor SI, Olefsky JM, Eds. Philadelphia, Lippicott Williams & Wilkins, 2000, p. 2-11
35. West IC: Radicals and oxidative stress in diabetes. Diabet Med 17:171-180, 2000
36. Paolisso G, Giugliano D: Oxidative stress and insulin action. Is there a relationship? Diabetologia 39:357-363, 1996
37. Rudich A, Kozlovsky N, Potashnik R, Bashan N: Oxidant stress reduces insulin responsiveness in 3T3-L1 adipocytes. Am J Physiol 35:E935-E940, 1997
38. Ceriello A: Oxidative stress and glycemic regulation. Metabolism 49:27-29, 2000
39. Yaworsky K, Somwar R, Klip A: Interrelationship between oxidative stress and insulin resistance. In Antioxidants in Diabetes Management. Packer L, Rösen P, Tritschler HJ, King GL, Eds. New York, Marcel Dekker, 2000, p. 275-302
40. Maddux BA, See W, Lawrence JC Jr, Goldfine AL, Goldfine ID, Evans JL: Protection against oxidative stress-induced insulin resistance in rat L6 muscle cells by micromolar concentrations of α-lipoic acid. Diabetes 50:404-410, 2001
41. Rudich A, Tirosh A, Potashnik R, Kharnaisi M, Bashan N: Lipoic acid protects against oxidative stress induced impairment in insulin stimulation of protein kinase B and glucose transport in 3T3-L1 adipocytes. Diabetologia 42:949-957, 1999
42. Packer L, Rosen P, Tritschler H, King GL, Azzi A (Eds): Antioxidants and Diabetes Management. New York, Marcel Dekker, 2000
43. Jacob S, Lehmann R, Rett K, Häring H-U: Oxidative stress and insulin action: A role for antioxidants. In Antioxidants in Diabetes Management. Packer L, Rösen P, Tritschler HJ, King GL, Eds. New York, Marcel Dekker, 2000, p. 319-338
44. Evans JL, Goldfine ID: α-Lipoic acid: A multi-functional antioxidant that improves insulin sensitivity in patients with type 2 diabetes. Diabetes Technol Ther 2:401-413, 2000
45. Inzucchi SE, Maggs DG, Spollett GR, Page SL, Rife FS, Walton V, Shulman GI: Efficacy and metabolic effects of metformin and troglitazone in type II diabetes mellitus. N Engl J Med 338:867-872, 1998
46. Mayerson AB, Hundal RS, Dufour S, Lebon V, Befroy D, Cline GW, Enocksson S, Inzucchi SE, Shulman GI, Petersen KF: The effects of rosiglitazone on insulin sensitivity, lipolysis, and hepatic and skeletal muscle triglyceride content in patients with type 2 diabetes. Diabetes 51:797-802, 2002
47. Evans JL, Heymann CJ, Goldfine ID, Gavin LA: Pharmacokinetics, tolerability, and fructosamine-lowering effect of a novel, controlled release formulation of α-lipoic acid. Endocr Pract 8:29-35, 2002
48. Pjodkowaki RA, Grotz VL, Mudalar S, Henry RR: The effects of alpha-lipoic acid on glucose homeostasis in type 2 diabetes. J Invest Med 50:71A, 2002
49. Estrada DE, Ewart HS, Tsakiridis T, Volchuk A, Ramlal T, Tritschler HJ, Klip A: Stimulation of glucose uptake by the natural coenzyme α-lipoic acid/thioctic acid: Participation of elements of the insulin signaling pathway. Diabetes 45:1798-1804, 1996
50. Konrad D, Somwar R, Sweeney G, Yaworsky K, Hayashi M, Ramlal T, Klip A: The antihyperglycemic drug alpha-lipoic acid stimulates glucose uptake via both GLUT4 translocation and GLUT4 activation: Potential role of p38 mitogen-activated protein kinase in GLUT4 activation. Diabetes 50:1464-1471, 2001
51. Ramrath S, Tritschler HJ, Eckel J: Stimulation of cardiac glucose transport by thioctic acid and insulin. Horm Metab Res 31:632-635, 1999
52. Paz K, Hemi R, LeRoith D, Karasik A, Elhanany E, Kanety H, Zick Y: A molecular basis for insulin resistance: Elevated serine/threonine phosphorylation of IRS-1 and IRS-2 inhibits their binding to the juxtamembrane region of the insulin receptor and impairs their ability to undergo insulin-induced tyrosine phosphorylation. J Biol Chem 272:29911-29918, 1997
53. Birnbaum MJ: Turning down insulin signaling. J Clin Invest 108:655-659, 2001
54. Aguirre V, Uchida T, Yenush L, Davis R, White MF: The c-jun NH(2)terminal kinase promotes insulin resistance during association with insulin receptor substrate-1 and phosphorylation of Ser(307). J Biol Chem 275:9047-9054, 2000
55. Blair AS, Hajduch E, Litherland GJ, Hundal HS: Regulation of glucose transport and glycogen synthesis in L6 muscle cells during oxidative stress: Evidence for cross-talk between the insulin and SAPK2/p38 mitogen-activated protein kinase signaling pathways. J Biol Chem 274:36293-36299, 1999
56. Yuan M, Konstantopoulos N, Lee J, Hansen L, Li ZW, Karin M, Shoelson SE: Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of IKKβ. Science 293:1673-1677, 2001
57. Robertson RP, Chen M: A role for prostaglandin E in defective insulin secretion and carbohydrate intolerance in diabetes mellitus. J Clin Invest 60:747-753, 1977
58. Chen M, Robertson RP: Restoration of the acute insulin response by sodium salicylate: A glucose dose-related phenomenon. Diabetes 27:750-756, 1978
59. Kim JK, Kim YJ, Fillmore JJ, Chen Y, Moore I, Lee J, Yuan M, Li ZW, Karin M, Perret P, Shoelson SE, Shulman GI: Prevention of fat-induced insulin resistance by salicylate. J Clin Invest 108:437-446, 2001
60. Hundal RS, Mayerson AB, Petersen KF, Rife FS, Randhawa PS, Inzucchi SE, Shoelson SE, Shulman GI: Potential for a novel class of insulin sensitizing agents by inhibition of IKKβ activity (Abstract). Diabetes 50 (Suppl. 2): A117, 2001
61. Hotamisligil GS, Spiegelman BM: Tumor necrosis factor of a key component of the obesity-diabetes link. Diabetes 43:1271-1278, 1994
62. Cohen B, Novick D, Rubinstein M: Modulation of insulin activities by leptin. Science 274:1185-1188, 1996
63. Randle PJ, Kerbey AL, Espinal J: Mechanisms decreasing glucose oxidation in diabetes and starvation: Role of lipid fuels and hormones. Diabetes Metab Rev 623:638, 1988
64. Steppan CM, Bailey ST, Bhat S, Brown EJ, Banerjee RR, Wright CM, Patel HR, Ahima RS, Lazar MA: The hormone resistin links obesity to diabetes. Nature 409:307-312, 2001
65. Shulman GI: Cellular mechanisms of insulin resistance. J Clin Invest 106:171-176, 2000
66. Duplus E, Glorian M, Forest C: Fatty acid regulation of gene transcription. J Biol Chem 275:30749-30752, 2000
67. Slatter DA, Bolton CH, Bailey AJ: The importance of lipid-derived malondialdehyde in diabetes mellitus. Diabetologia 43:550-557, 2000
68. Paolisso G, Di Maro G, Pizza G, D'Amore A, Sgambato S, Tesauro P, Varricchio M, D'Onofrio F: Plasma GSH/GSSG affects glucose homeostasis in healthy subjects and non-insulin-dependent diabetics. Am J Physiol 263:E435-E440, 1992
69. Wojtczak L, Schonfeld P: Effect of fatty acids on energy coupling processes in mitochondria. Biochim Biophys Acta 1183:41-57, 1993
70. Bakker SJ, IJzerman RG, Teerlink T, Westerhoff HV, Gans RO, Heine RJ: Cytosolic triglycerides and oxidative stress in central obesity: The missing link between excessive atherosclerosis, endothelial dysfunction, and beta-cell failure? Atherosclerosis 148:17-21, 2000
71. Toborek M, Hennig B: Fatty acid-mediated effects on the glutathione redox cycle in cultured endothelial cells. Am J Clin Nutr 59:60-65, 1994
72. Hennig B, Meerarani P, Ramadass P, Watkins BA, Toborek M: Fatty acid-mediated activation of vascular endothelial cells. Metabolism 49:1006-1013, 2000
73. Dichtl W, Nilsson L, Goncalves I, Ares MP, Banfi C, Calara F, Hamsten A, Eriksson P, Nilsson J: Very low-density lipoprotein activates nuclear factor-kappaB in endothelial cells. Circ Res 84:1085-1094, 1999
74. Hennig B, Meerarani P, Toborek M, McClain CJ: Antioxidant-like properties of zinc in activated endothelial cells. J Am Coll Nutr 18:152-158, 1999
75. Lee JY, Sohn KH, Rhee SH, Hwang D: Saturated fatty acids, but not unsaturated fatty acids, induce the expression of cyclooxygenase-2 mediated through toll-like receptor 4. J Biol Chem 276:16683-16689, 2001
76. Griffin ME, Marcucci MJ, Cline GW, Bell K, Barucci N, Lee D, Goodyear LJ, Kraegen EW, White MF, Shulman GI: Free fatty acid-induced insulin resistance is associated with activation of protein kinase C θ and alterations in the insulin signaling cascade. Diabetes 48:1270-1274, 1999
77. Coudronniere N, Villalba M, Englund N, Altman A: NF-kappa B activation induced by T cell receptor/CD28 co-stimulation is mediated by protein kinase C-theta. Proc Natl Acad Sci U S A 97:3394-3399, 2000
78. Meglasson MD, Matschinsky FM: Pancreatic islet glucose metabolism and regulation of insulin secretion. Diabetes Metab Rev 2:163-214, 1986
79. Malaisse WJ: Physiology, pathology and pharmacology of insulin secretion: Recent acquisitions. Diabetes Metab 23:6-15, 1997
80. Maechler P, Jornot L, Wollheim CB: Hydrogen peroxide alters mitochondrial activation and insulin secretion in pancreatic beta cells. J Biol Chem 274:27905-27913, 1999
81. Robertson RP, Harmon JS, Tanaka Y, Sacchi G, Tran PO, Gleason CE, Poitout V: Glucose toxicity of the β-cell: Cellular and molecular mechanisms. In Diabetes Mellitus: A Fundamental and Clinical Text. Le Roith D, Taylor SI, Olefsky JM, Eds. Philadelphia, Lippincott Williams & Wilkins, 2000, p. 125-132
82. Bolaffi JL, Bruno L, Heldt A, Grodsky GM: Characteristics of desensitization of insulin secretion in fully in vitro systems. Endocrinology 122:1801-1809, 1988
83. Tiedge M, Lortz S, Drinkgern J, Lenzen S: Relation between antioxidant enzyme gene expression and antioxidative defense status of insulin-producing cells. Diabetes 46:1733-1742, 1997
84. Tiedge M, Lortz S, Munday R, Lenzen S: Complementary action of antioxidant enzymes in the protection of bioengineered insulin-producing RINm5F cells against the toxicity of reactive oxygen species. Diabetes 47:1578-1585, 1998
85. Benhamou PY, Moriscot C, Richard MJ, Beatrix O, Badet L, Pattou F, Kerr-Conte J, Chroboczek J, Lemarchand P, Halimi S: Adenovirus-mediated catalase gene transfer reduces oxidant stress in human, porcine and rat pancreatic islets. Diabetologia 41:1093-1100, 1998
86. Miwa I, Ichimura N, Sugiura M, Hamada Y, Taniguchi S: Inhibition of glucose-induced insulin secretion by 4-hydroxy-2-nonenal and other lipid peroxidation products. Endocrinology 141:2767-2772, 2000
87. Tanaka Y, Gleason CE, Tran PO, Harmon JS, Robertson RP: Prevention of glucose toxicity in HIT-T15 cells and Zucker diabetic fatty rats by antioxidants. Proc Natl Acad Sci U S A 96:10857-10862, 1999
88. Ho E, Bray TM: Antioxidants, NF-kappaB activation, and diabetogenesis. Proc Roe Soc Exp Biol Med 222:205-213, 1999
89. Tajiri Y, Moller C, Grill V: Long-term effects of aminoguanidine on insulin release and biosynthesis: Evidence that the formation of advanced glycosylation end products inhibits β-cell function. Endocrinology 138:273-280, 1997
90. Ho E, Chen G, Bray TM: Supplementation of N-acetylcysteine inhibits NF-kappaB activation and protects against alloxan-induced diabetes in CD-1 mice. FASEB J 13:1845-1854, 1999
91. Ho E, Chen G, Bray TM: Alpha-phenyl-tert-butyinitrone (PBN) inhibits NFkappaB activation offering protection against chemically induced diabetes. Free Radic Biol Med 28:604-614, 2000
92. Kaneto H, Xu G, Song KH, Suzuma K, Bonner-Weir S, Sharma A, Weir GC: Activation of the hexosamine pathway leads to deterioration of pancreatic beta-cell function through the induction of oxidative stress. J Biol Chem 276:31099-31104, 2001
93. Boden G, Ruiz J, Kim CJ, Chen X: Effects of prolonged glucose infusion on insulin secretion, clearance, and action in normal subjects. Am J Physiol 270:E251-E258, 1996
94. Robertson RP, Zhang HJ, Pyzdrowski KL, Walseth TF: Preservation of insulin mRNA levels and insulin secretion in HIT cells by avoidance of chronic exposure to high glucose concentrations. J Clin Invest 90:320-325, 1992
95. Poitout V, Olson LK, Robertson RP: Chronic exposure of beta TC-6 cells to supraphysiologic concentrations of glucose decreases binding of the RIPE3b1 insulin gene transcription activator. J Clin Invest 97:1041-1046, 1996
96. Carlsson C, Borg LA, Welsh N: Sodium palmitate induces partial mitochondrial uncoupling and reactive oxygen species in rat pancreatic islets in vitro. Endocrinology 140:3422-3428, 1999
97. Zhou YP, Grill VE: Long-term exposure of rat pancreatic islets to fatty acids inhibits glucose-induced insulin secretion and biosynthesis through a glucose fatty acid cycle. J Clin Invest 93:870-876, 1994
98. Bollheimer LC, Skelly RH, Chester MW, McGarry JD, Rhodes CJ: Chronic exposure to free fatty acid reduces pancreatic beta cell insulin content by increasing basal insulin secretion that is not compensated for by a corresponding increase in proinsulin biosynthesis translation. J Clin Invest 101:1094-1101, 1998
99. Unger RH, Zhou YT: Lipotoxicity of β-cells in obesity and in other causes of fatty acid spillover. Diabetes 50 (Suppl. 1): S118-S121, 2001
100. Lameloise N, Muzzin P, Prentki M, Assimacopoulos-Jeannet F: Uncoupling protein 2: A possible link between fatty acid excess and impaired glucose-induced insulin secretion? Diabetes 50:803-809, 2001
101. Segall L, Lameloise N, Assimacopoulos-Jeannet F, Roche E, Corkey P, Thumelin S, Corkey BE, Prentki M: Lipid rather than glucose metabolism is implicated in altered insulin secretion caused by oleate in INS-1 cells. Am J Physiol 277:E521-E528, 1999
102. Jacqueminet S, Briaud I, Rouault C, Reach G, Poitout V: Inhibition of insulin gene expression by long-term exposure of pancreatic beta cells to palmitate is dependent on the presence of a stimulatory glucose concentration. Metabolism 49:532-536, 2000
103. Nadler JL, Natarajan Natarojan R: Oxidative stress, inflammation, and diabetic complications. In Diabetes Mellitus: A Fundamental and Clinical Text. LeRoith D, Taylor SI, Olefsky JM, Eds. Philadelphia-Lippincott Williams & Wilkins, 2000, p. 1008-1016
104. Brown BG, Zhao XQ, Chait A, Fisher LD, Cheung MC, Morse JS, Dowdy AA, Marino EK, Bolson EL, Alaupovic P, Frohlich J, Albers JJ: Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease. N Engl J Med 345:1583-1592, 2001
105. Yusuf S, Dagenais G, Pogue J, Bosch J, Sleight P: Vitamin E supplementation and cardiovascular events in high-risk patients: The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med 342:154-160, 2000
106. Jacob S, Ruus P, Hermann R, Tritschler HJ, Maerker E, Renn W, Augustin HJ, Dietze GJ, Rett K: Oral administration of RAC-alpha-lipoic acid modulates insulin sensitivity in patients with type 2 diabetes mellitus: A placebo-controlled pilot trial. Free Radic Biol Med 27:309-314, 1999
107. Jacob S, Henriksen EJ, Tritschler HJ, Augustin HJ, Dietze GJ: Improvement of insulin-stimulated glucose-disposal in type 2 diabetes after repeated parenteral administration of thioctic acid. Exp Clin Endocrinol Diabetes 104:284-288, 1996
108. Jacob S, Henriksen EJ, Schiemann AL, Simon I, Clancy DE, Tritschler HJ, Jung WI, Augustin HJ, Dietze GJ: Enhancement of glucose disposal in patients with type 2 diabetes by alpha-lipoic acid. Arzneimittelforschung 45:872-874, 1995